New Drug's first human test paves way for future cancer and infection research
Knowledge-focused
Completed
This was a first-in-human study to check the safety and how the body processes a new drug called Benfo-Oxythiamine (B-OT). The study involved 48 healthy male volunteers who took the drug as a capsule and were closely monitored. The goal was to gather basic safety data to see if t…
Phase: PHASE1 • Sponsor: Benfovir AG • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC